Viewing Study NCT06503250


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-03-18 @ 12:31 AM
Study NCT ID: NCT06503250
Status: COMPLETED
Last Update Posted: 2025-03-21
First Post: 2024-07-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module